Get More Information on Allergy Diagnostics Market - Request Sample Report
The Allergy Diagnostics Market Size was valued at USD 4.91 billion in 2023 and is expected to reach USD 13.68 billion by 2032 at a CAGR of 12.06% during the forecast period of 2024-2032.
The rise in the allergic population and increasing incidence of allergies is one of the key factors contributing to allergy diagnostics market growth. It is due to the high-risk factors for the development of chronic respiratory diseases including an increase in exposure to outdoor and indoor air pollutants and occupational exposure. The number of those suffering from allergies is much greater in the urban population compared to the rural population due to increased exposure to environmental pollutants from industrial processes and urbanization.
For example, as per the statistics, published by the World Health Organisation in January 2023, around 1 in 4 children and 1 in 3 adults has a seasonal allergy in the U.S. So, there are about 27.69 million and 66 million people have seasonal allergies among the total population of 331 million. Additionally, nearly 6% of children and adults in the U.S. have a food allergy being highest among black, Asian, and Hispanic persons. Similarly, as per the statistics given by the Asthma and Allergy Foundation of America in 2021, about 81 million people are suffering from seasonal allergic rhinitis in the U.S. among which around 26% of adults and 19% of children are affected.
Moreover, government initiatives and healthcare policies have also significantly contributed to the market's expansion. For instance, in the U.S., the Centers for Disease Control and Prevention and other public health agencies have been actively promoting the importance of allergy testing as part of public health strategies to manage allergic diseases. In Europe, government-funded healthcare systems have integrated allergy diagnostics into routine healthcare, ensuring broader access to these essential tests. These factors combined are driving the growth of the allergy diagnostics market.
In Australia, the government has recognized the rising prevalence of allergies, leading to the establishment of the National Allergy Strategy in collaboration with the Australasian Society of Clinical Immunology and Allergy (ASCIA). This initiative focuses on improving access to allergy diagnostics and management, reflecting the growing demand for these services in the healthcare system.
Drivers
The rising uses of in vitro diagnostics are mainly prompted by the increasing prevalence of chronic diseases, the rising demand to diagnose diseases early and correctly, and the evolution of personalized medicine. On the one hand, a significant number of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, among others, have become substantially more prevalent in the world. Therefore, healthcare systems have come to prioritize the early detection of these diseases, a process highly facilitated by the application of the in vitro diagnostic. On the other hand, the introduction of such technologies as next-generation sequencing and diagnostic tools based on artificial intelligence applications, among others, has substantially increased the accuracy and efficiency of the in vitro diagnostic.
Moreover, the popularity of the application of in vitro diagnostics in the era of precision medicine can be largely confirmed by the Food and Drug Administration’s approval of several next-generation sequencing in vitro diagnostics in recent years. Moreover, similar initiatives of other governmental bodies in the United States and the European Union provide further support of the in vitro diagnostic’s rising popularity in modern healthcare systems.
Restraint
The high costs related to allergy diagnostics are factor that hampered the broad use of the discussed tests. For the most part, allergy testing is associated with the use of efficient diagnostic equipment, such as immunoassay analyzers and skin testing devices, and consumables, including allergen extracts and reagents. The specified components are crucial for a highly accurate and dependable diagnosis. However, each of the items that have been listed above is connected to a hefty price. From the part of healthcare providers, it involves the initial cost of implementation of the technology, as well as the expenses related to maintenance and recurring consumables purchase.
By Type
In the allergy diagnostics market, consumables held the largest market share. This segment includes items such as reagents, test kits, and other disposable materials required for allergy testing. The high demand for consumables-type products is driven by their recurring nature; they are essential for every test conducted, making them a continuous revenue stream for manufacturers. Additionally, the increasing prevalence of allergies worldwide has led to a rise in the number of tests performed, further boosting the demand for consumables. The frequent use and replenishment of these products in both large and small healthcare settings, coupled with the ongoing development of new and more effective diagnostic tests, solidify the consumables segment as the market leader.
By Test Type
The in vitro test segment held the largest market share of 54.23% in 2023. This test is used to determine allergen-specific immunoglobulin E. It has been found that Serum IgE has a high positive predictive value and improved specificity for identifying aeroallergen sensitization. It is believed that factors, such as, food allergy are growing as a major public health issue worldwide where the incidence of food allergy and sensitization is increasing both in developed nations & developing nations across the globe is expected to have a significant impact on allergy diagnostics market penetration during the forecast period. For example, according to Food Allergy Research and Education’s 2022 statistics, it is estimated that around 2.8 million Americans may have an egg allergy in 2020 while 2.5 million might have a wheat allergy.
Need any customization research on Allergy Diagnostics Market - Enquiry Now
By Allergen
The inhaled allergens segment dominated the market with the highest share around 48.68% in 2023. The growth is driven by the increasing incidence of respiratory allergies induced by industrialization and escalating air pollution. The Allergy and Asthma Foundation of America estimated that the prevalence of seasonal allergic rhinitis in the U.S. would reach approximately 81 million in 2021, with about 26% of 67 million adults and 19% of 14 million minors accounted for the estimate. The number is expected to increase over the forecast period. Hence, the growing prevalence of allergic rhinitis is anticipated to offer future growth opportunities for the market.
By End-User
Hospital-based Laboratories & Clinics held the largest market share around 32.65% in 2023. This is because of the comprehensive nature of the service these facilities offer, where allergy diagnostics are a crucial component of broader healthcare services. Hospitals and clinics have access to various diagnostic tools and technologies, allowing them to conduct detailed and accurate allergy tests. Additionally, these facilities are often the first point of contact for patients experiencing allergic reactions, making them essential in both the initial diagnosis and ongoing management of allergies.
North America held the highest market share in the allergy diagnostics market about 38.21% in 2023. This can be referred to the increasing incidences of allergy and favorable government initiatives in the region. It is known that North America is a developed region with high healthcare expenditure. The research shows that U.S.-based firms have made substantial investments in the development of these kinds of drugs as they have an increased understanding of the large target population. In addition, the key players focused on entering the market with its innovations and products is expected to escalate and enhance the competitive rivalry in the North American market.
Asia Pacific market is expected to grow at a lucrative rate due to a number of factors. These factors include increasing healthcare reforms and developing healthcare infrastructure. Other factors that have facilitated the growth of the market are increasing population, rising prevalence of allergies, and a growing number of local companies entering the market. With Japan, China, and India being major markets in Asia Pacific, its growth is projected to lower the market in the region. Players in these countries have taken varied strategies to increase their market dominance.
The Major Players are Thermo Fisher Scientific, Inc., DASIT Group SPA, AESKU.GROUP GmbH, Astellas Pharma Inc., Epigenomics AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., AbbVie, Inc., Lincoln Diagnostics, Inc. & Other Players
In 2023, Thermo Fisher launched an advanced allergy test that provides faster and more accurate results. This development aims to enhance the diagnostic capabilities of healthcare providers, addressing the growing demand for precision medicine in allergy diagnostics.
In 2022, Siemens Healthineers launched a new automated allergy testing platform, which help to reduce the time required for testing multiple allergens simultaneously.
| Report Attributes | Details |
| Market Size in 2023 | US$ 4.91 Billion |
| Market Size by 2032 | US$ 13.68 Billion |
| CAGR | CAGR of12.06 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Consumables, Instruments, Services) • By Test Type (In Vivo Test, In Vitro Test) • By Allergen, (Inhaled Allergens, Food Allergens, Drug Allergens, and Other Allergens) • By End-User (Hospital-based Laboratories & Clinics, Diagnostic Laboratories, Academic Research Institutes) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., DASIT Group SPA, AESKU.GROUP GmbH, Astellas Pharma Inc., Epigenomics AG, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd., Pfizer, Inc., AbbVie, Inc., Lincoln Diagnostics, Inc. |
| Key Drivers | •The growing use of in vitro diagnostic techniques drives the market growth. |
| RESTRAINTS | •The high cost of allergy diagnostic procedures hampers the market growth. |
Ans: The Allergy Diagnostics Market was valued at USD 4.91 billion in 2023.
Ans: The expected CAGR of the global Allergy Diagnostics Market during the forecast period is 12.06%.
Ans: The In Vivo Test will grow rapidly in the Allergy Diagnostics Market from 2024-2032.
Ans: The high cost of allergy diagnostic procedures hampers the market growth.
Ans: North America led the allergy diagnostics market with the highest revenue share in 2023.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Allergy Diagnostics Market Segmentation, by Type
7.1 Chapter Overview
7.2 Consumables
7.2.1 Consumables Market Trends Analysis (2020-2032)
7.2.2 Consumables Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Instruments
7.3.1 Instruments Market Trends Analysis (2020-2032)
7.3.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Services
7.4.1 Services Market Trends Analysis (2020-2032)
7.4.2 Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Allergy Diagnostics Market Segmentation, by Test Type
8.1 Chapter Overview
8.2 In Vivo Test
8.2.1 In Vivo Test Market Trends Analysis (2020-2032)
8.2.2 In Vivo Test Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 In Vitro Test
8.3.1 In Vitro Test Market Trends Analysis (2020-2032)
8.3.2 In Vitro Test Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Allergy Diagnostics Market Segmentation, by Allergen
9.1 Chapter Overview
9.2 Inhaled Allergens
9.2.1 Inhaled Allergens Market Trends Analysis (2020-2032)
9.2.2 Inhaled Allergens Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Food Allergens
9.3.1 Food Allergens Market Trends Analysis (2020-2032)
9.3.2 Food Allergens Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Drug Allergens
9.4.1 Drug Allergens Market Trends Analysis (2020-2032)
9.4.2 Drug Allergens Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others Allergens
9.4.1 Others Allergens Market Trends Analysis (2020-2032)
9.4.2 Others Allergens Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Allergy Diagnostics Market Segmentation, by End-User
10.1 Chapter Overview
10.2 Hospital-based Laboratories & Clinics
10.2.1 Hospital-based Laboratories & Clinics Market Trends Analysis (2020-2032)
10.2.2 Hospital-based Laboratories & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Diagnostic Laboratories
10.3.1 Diagnostic Laboratories Market Trends Analysis (2020-2032)
10.3.2 Diagnostic Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Academic Research Institutes
10.4.1 Academic Research Institutes Market Trends Analysis (2020-2032)
10.4.2 Academic Research Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.2.3 North America Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.4 North America Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.2.5 North America Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.2.6 North America Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.7.2 USA Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.2.7.3 USA Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.2.7.4 USA Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.8.2 Canada Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.2.8.3 Canada Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.2.8.4 Canada Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.9.2 Mexico Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.2.9.3 Mexico Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.2.9.4 Mexico Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.1.3 Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.4 Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.1.5 Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.1.6 Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.1.7 Poland
11.3.1.7.1 Poland Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.7.2 Poland Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.1.7.3 Poland Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.1.7.4 Poland Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.1.8 Romania
11.3.1.8.1 Romania Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.8.2 Romania Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.1.8.3 Romania Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.1.8.4 Romania Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.9.2 Hungary Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.1.9.3 Hungary Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.1.9.4 Hungary Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.10.2 Turkey Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.1.10.3 Turkey Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.1.10.4 Turkey Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.11.2 Rest of Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.1.11.3 Rest of Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.1.11.4 Rest of Eastern Europe Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.2.3 Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.4 Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.5 Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.6 Western Europe Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.7 Germany
11.3.2.7.1 Germany Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.7.2 Germany Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.7.3 Germany Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.7.4 Germany Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.8 France
11.3.2.8.1 France Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.8.2 France Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.8.3 France Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.8.4 France Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.9 UK
11.3.2.9.1 UK Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.9.2 UK Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.9.3 UK Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.9.4 UK Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.10 Italy
11.3.2.10.1 Italy Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.10.2 Italy Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.10.3 Italy Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.10.4 Italy Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.11 Spain
11.3.2.11.1 Spain Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.11.2 Spain Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.11.3 Spain Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.11.4 Spain Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.12.2 Netherlands Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.12.3 Netherlands Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.12.4 Netherlands Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.13.2 Switzerland Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.13.3 Switzerland Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.13.4 Switzerland Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.14 Austria
11.3.2.14.1 Austria Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.14.2 Austria Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.14.3 Austria Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.14.4 Austria Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.15.2 Rest of Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.3.2.15.3 Rest of Western Europe Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.3.2.15.4 Rest of Western Europe Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.4.3 Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.4 Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.5 Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.6 Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.7.2 China Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.7.3 China Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.7.4 China Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.8.2 India Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.8.3 India Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.8.4 India Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.9.2 Japan Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.9.3 Japan Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.9.4 Japan Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.10.2 South Korea Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.10.3 South Korea Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.10.4 South Korea Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.11 Vietnam
11.4.11.1 Vietnam Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.11.2 Vietnam Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.11.3 Vietnam Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.11.4 Vietnam Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.12 Singapore
11.4.12.1 Singapore Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.12.2 Singapore Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.12.3 Singapore Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.12.4 Singapore Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.13 Australia
11.4.13.1 Australia Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.13.2 Australia Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.13.3 Australia Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.13.4 Australia Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.14.2 Rest of Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.4.14.3 Rest of Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.4.14.4 Rest of Asia Pacific Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.1.3 Middle East Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.4 Middle East Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.1.5 Middle East Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.1.6 Middle East Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.1.7 UAE
11.5.1.7.1 UAE Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.7.2 UAE Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.1.7.3 UAE Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.1.7.4 UAE Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.8.2 Egypt Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.1.8.3 Egypt Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.1.8.4 Egypt Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.9.2 Saudi Arabia Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.1.9.3 Saudi Arabia Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.1.9.4 Saudi Arabia Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.10.2 Qatar Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.1.10.3 Qatar Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.1.10.4 Qatar Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.11.2 Rest of Middle East Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.1.11.3 Rest of Middle East Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.1.11.4 Rest of Middle East Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.2.3 Africa Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.4 Africa Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.2.5 Africa Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.2.6 Africa Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.7.2 South Africa Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.2.7.3 South Africa Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.2.7.4 South Africa Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.8.2 Nigeria Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.2.8.3 Nigeria Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.2.8.4 Nigeria Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.9.2 Rest of Africa Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.5.2.9.3 Rest of Africa Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.5.2.9.4 Rest of Africa Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Allergy Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.6.3 Latin America Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.4 Latin America Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.6.5 Latin America Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.6.6 Latin America Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.7.2 Brazil Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.6.7.3 Brazil Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.6.7.4 Brazil Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.8.2 Argentina Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.6.8.3 Argentina Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.6.8.4 Argentina Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.6.9 Colombia
11.6.9.1 Colombia Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.9.2 Colombia Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.6.9.3 Colombia Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.6.9.4 Colombia Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Allergy Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.10.2 Rest of Latin America Allergy Diagnostics Market Estimates and Forecasts, by Test Type (2020-2032) (USD Billion)
11.6.10.3 Rest of Latin America Allergy Diagnostics Market Estimates and Forecasts, by Allergen (2020-2032) (USD Billion)
11.6.10.4 Rest of Latin America Allergy Diagnostics Market Estimates and Forecasts, by End-User (2020-2032) (USD Billion)
12. Company Profiles
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 DASIT Group SPA
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 AESKU.GROUP GmbH
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Astellas Pharma Inc.
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Epigenomics AG
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Sun Pharmaceutical Industries Ltd
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Teva Pharmaceutical Industries Ltd.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Pfizer, Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 AbbVie, Inc.
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Lincoln Diagnostics, Inc.
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Consumables
Instruments
Services
By Test Type
In Vivo Test
In Vitro Test
By Allergen
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
By End-User
Hospital-based Laboratories & Clinics
Diagnostic Laboratories
Academic Research Institutes
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Compression Therapy Market size was valued at USD 4.06 Billion in 2023 & is estimated to reach USD 7.86 Billion by 2032 with a growing CAGR of 7.63% over the forecast period of 2024-2032.
The High Throughput Screening Market Size was valued at USD 25.80 billion in 2023 and is witnessed to reach USD 69.46 Billion by 2032 and grow at a CAGR of 12.18% over the forecast period 2024-2032.
The Biotechnology Reagents & Kits Market size was estimated at USD 660.67 billion in 2023 and is expected to reach USD 1690.01 billion by 2032 with a growing CAGR of 11% during the forecast period of 2024-2032.
The Drug Eluting Stent Market size was estimated at USD 7.80 Billion in 2023 and is expected to reach USD 14.98 Billion by 2031 at a CAGR of 8.5% during the forecast period of 2024-2031.
The Pharmaceutical Cartridges Market Size was valued at USD 1.41 Billion in 2023 and is expected to reach USD 2.86 Billion by 2032 and grow at a CAGR of 8.57% over the forecast period 2024-2032.
The Artificial Tears Market size was USD 3.25 Billion in 2023 and is expected to reach USD 5.72 Billion by 2032 and grow at a CAGR of 6.49% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
